Brief: Veraxa Biotech Initiates Cell Line Development With ATUM
02/07/2026 13:32
BRIEF-Veraxa Biotech Initiates Cell Line Development With ATUM July 2 (Reuters) - Veraxa Biotech AG VRXA.O:
INITIATES CELL LINE DEVELOPMENT WITH ATUM TO ADVANCE ITS LEAD BITAC®-TCE PROGRAM
Source text: ID:nGNX8xNQt4
Further company coverage: VRXA.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Veraxa Biotech AG
See all newsBrief: Veraxa Biotech Holding AG - Files To Register Resale Of Up To 25 Million Ordinary Shares - SEC Filing
Brief: Veraxa Biotech Shareholders Approve All Proposals At Extraordinary General Meeting, Strengthening Strategic Flexibility For Future Growth
Brief: Veraxa Biotech Initiates Cell Line Development With ATUM
NASDAQ RESUMED AT 01:08 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM